We are live on ! Find out more
AS

Altshuler Shaham Portfolio holdings

AUM $8.04B
1-Year Est. Return 44.04%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+44.04%
3 Year Est. Return
+108.34%
5 Year Est. Return
+71.14%
10 Year Est. Return
AUM
$11.7B
AUM Growth
-$1.94B
Cap. Flow
-$2.13B
Cap. Flow %
-18.17%
Top 10 Hldgs %
83.09%
Holding
694
New
193
Increased
104
Reduced
140
Closed
165
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOV icon
401
Dover
DOV
$27.8B
$52K ﹤0.01%
287
-1,085
-79% -$184K
MRK icon
402
Merck
MRK
$334B
$52K ﹤0.01%
661
-1,870
-74% -$149K
OPCH icon
403
Option Care Health
OPCH
$3.61B
$52K ﹤0.01%
+1,835
New +$48.2K
PINC
404
DELISTED
Premier
PINC
$52K ﹤0.01%
+1,268
New +$50K
RVTY icon
405
Revvity
RVTY
$13.1B
$52K ﹤0.01%
258
-422
-62% -$76.3K
TECH icon
406
Bio-Techne
TECH
$11.2B
$52K ﹤0.01%
404
-52
-11% -$6.38K
TVTX icon
407
Travere Therapeutics
TVTX
$5.79B
$52K ﹤0.01%
+1,663
New +$46.8K
WAT icon
408
CALL
Waters Corp
WAT
$40.6B
$52K ﹤0.01%
+139
New +$48.6K
ABT icon
409
Abbott
ABT
$193B
$51K ﹤0.01%
361
-28
-7% -$3.58K
AVTR icon
410
Avantor
AVTR
$9.37B
$51K ﹤0.01%
1,210
-23
-2% -$907
CHE icon
411
Chemed
CHE
$7.02B
$51K ﹤0.01%
97
-8
-8% -$3.84K
CRVL icon
412
CorVel
CRVL
$3.25B
$51K ﹤0.01%
729
-162
-18% -$10.2K
HRMY icon
413
Harmony Biosciences
HRMY
$2.24B
$51K ﹤0.01%
+1,202
New +$47.9K
LH icon
414
Labcorp
LH
$26.2B
$51K ﹤0.01%
187
-605
-76% -$150K
RIOT icon
415
Riot Platforms
RIOT
$7.21B
$51K ﹤0.01%
2,000
EGRX
416
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$51K ﹤0.01%
+1,004
New +$52K
ALKS icon
417
Alkermes
ALKS
$8.3B
$50K ﹤0.01%
2,131
-1,938
-48% -$51K
ANGO icon
418
AngioDynamics
ANGO
$647M
$50K ﹤0.01%
1,805
+38
+2% +$1.05K
BRKR icon
419
Bruker
BRKR
$8.83B
$50K ﹤0.01%
591
-739
-56% -$59.2K
DHR icon
420
Danaher
DHR
$143B
$50K ﹤0.01%
173
-24
-12% -$6.61K
FAST icon
421
Fastenal
FAST
$58.9B
$50K ﹤0.01%
1,566
+1,280
+448% +$37.7K
GILD icon
422
Gilead Sciences
GILD
$171B
$50K ﹤0.01%
686
-1,901
-73% -$131K
HSIC icon
423
Henry Schein
HSIC
$10B
$50K ﹤0.01%
641
+1
+0.2% +$76
IQV icon
424
IQVIA
IQV
$39.8B
$50K ﹤0.01%
177
-44
-20% -$11.4K
PBH icon
425
Prestige Consumer Healthcare
PBH
$2.43B
$50K ﹤0.01%
826
-47
-5% -$2.79K

Similar funds

Altshuler Shaham's Q4 2021 Portfolio in Review

As of Q4 2021, Altshuler Shaham held 694 positions worth $11.7B, down 14% from $13.6B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Altshuler Shaham withdrew a net $2.13B in Q4 2021, closing 165 positions and reducing 140 holdings. Its most notable exit was Mastercard, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 36% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Altshuler Shaham opened a new position in Citigroup worth $152M.

  • Altshuler Shaham's largest Q4 2021 buy was Citigroup: 2,515,900 shares worth $152M.
  • Altshuler Shaham added most to Global X Copper Miners ETF NEW in Q4 2021, an estimated $761M increase.
  • Altshuler Shaham's biggest Q4 2021 reduction was Apple, cutting an estimated $929M.
  • Altshuler Shaham fully exited Mastercard in Q4 2021, selling an estimated $383M.
  • Altshuler Shaham's ten largest holdings make up 83% of its $11.7B portfolio in Q4 2021.
  • Altshuler Shaham opened 193 new positions and closed 165 in Q4 2021.
  • Altshuler Shaham's portfolio value fell 14% quarter-over-quarter to $11.7B.

Based on Altshuler Shaham's 13F filing for Q4 2021, filed 15 Feb 2022.